dopamine: be contraindicated in shock

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents neurotransmitter
Weight: 0.73
, chemical
Weight: 0.69
, hormone
Weight: 0.68
, neuron
Weight: 0.67
, drug
Weight: 0.67
Siblings acetylcholine
Weight: 0.41
, serotonin
Weight: 0.41
, vasopressin
Weight: 0.39
, oxytocin
Weight: 0.39
, norepinephrine
Weight: 0.38

Related properties

Property Similarity
be contraindicated in shock 1.00
be contraindicated in hypovolemic shock 0.99
be contraindicated in pheochromocytoma 0.91
be used in cardiogenic shock 0.80
be given for cardiovascular shock 0.76
be used in shock 0.76
be prefered over adrenaline in cardiogenic shock 0.76

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.04
Rule weight: 0.13
Evidence weight: 0.35
Similarity weight: 0.76
Evidence: 0.79
¬ Remarkable(dopamine, be contraindicated in shock)
Evidence: 0.82
¬ Remarkable(vasopressin, be used in shock)

Remarkability from sibling implausibility

0.42
Rule weight: 0.60
Evidence weight: 0.93
Similarity weight: 0.76
Evidence: 0.58
Plausible(dopamine, be contraindicated in shock)
Evidence: 0.82
Remarkable(vasopressin, be used in shock)
Evidence: 0.94
¬ Plausible(vasopressin, be used in shock)

Salient implies Plausible

0.19
Rule weight: 0.28
Evidence weight: 0.69
Similarity weight: 1.00
Evidence: 0.58
Plausible(dopamine, be contraindicated in shock)
Evidence: 0.73
¬ Salient(dopamine, be contraindicated in shock)

Similarity expansion

0.71
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.99
Evidence: 0.79
Remarkable(dopamine, be contraindicated in shock)
Evidence: 0.78
¬ Remarkable(dopamine, be contraindicated in hypovolemic shock)
0.68
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.99
Evidence: 0.73
Salient(dopamine, be contraindicated in shock)
Evidence: 0.75
¬ Salient(dopamine, be contraindicated in hypovolemic shock)
0.67
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.91
Evidence: 0.79
Remarkable(dopamine, be contraindicated in shock)
Evidence: 0.61
¬ Remarkable(dopamine, be contraindicated in pheochromocytoma)
0.64
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.91
Evidence: 0.73
Salient(dopamine, be contraindicated in shock)
Evidence: 0.63
¬ Salient(dopamine, be contraindicated in pheochromocytoma)
0.63
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.99
Evidence: 0.58
Plausible(dopamine, be contraindicated in shock)
Evidence: 0.60
¬ Plausible(dopamine, be contraindicated in hypovolemic shock)
0.62
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.99
Evidence: 0.52
Typical(dopamine, be contraindicated in shock)
Evidence: 0.55
¬ Typical(dopamine, be contraindicated in hypovolemic shock)
0.61
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.80
Evidence: 0.52
Typical(dopamine, be contraindicated in shock)
Evidence: 0.23
¬ Typical(dopamine, be used in cardiogenic shock)
0.60
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.76
Evidence: 0.79
Remarkable(dopamine, be contraindicated in shock)
Evidence: 0.33
¬ Remarkable(dopamine, be given for cardiovascular shock)
0.59
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.76
Evidence: 0.73
Salient(dopamine, be contraindicated in shock)
Evidence: 0.34
¬ Salient(dopamine, be given for cardiovascular shock)
0.59
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.91
Evidence: 0.58
Plausible(dopamine, be contraindicated in shock)
Evidence: 0.56
¬ Plausible(dopamine, be contraindicated in pheochromocytoma)
0.58
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.80
Evidence: 0.73
Salient(dopamine, be contraindicated in shock)
Evidence: 0.58
¬ Salient(dopamine, be used in cardiogenic shock)
0.57
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.80
Evidence: 0.58
Plausible(dopamine, be contraindicated in shock)
Evidence: 0.39
¬ Plausible(dopamine, be used in cardiogenic shock)
0.56
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.76
Evidence: 0.79
Remarkable(dopamine, be contraindicated in shock)
Evidence: 0.59
¬ Remarkable(dopamine, be prefered over adrenaline in cardiogenic shock)
0.56
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.80
Evidence: 0.79
Remarkable(dopamine, be contraindicated in shock)
Evidence: 0.86
¬ Remarkable(dopamine, be used in cardiogenic shock)
0.55
Rule weight: 0.85
Evidence weight: 0.71
Similarity weight: 0.91
Evidence: 0.52
Typical(dopamine, be contraindicated in shock)
Evidence: 0.59
¬ Typical(dopamine, be contraindicated in pheochromocytoma)
0.55
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.76
Evidence: 0.79
Remarkable(dopamine, be contraindicated in shock)
Evidence: 0.73
¬ Remarkable(dopamine, be used in shock)
0.54
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.76
Evidence: 0.58
Plausible(dopamine, be contraindicated in shock)
Evidence: 0.41
¬ Plausible(dopamine, be given for cardiovascular shock)
0.53
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.76
Evidence: 0.73
Salient(dopamine, be contraindicated in shock)
Evidence: 0.64
¬ Salient(dopamine, be used in shock)
0.53
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.76
Evidence: 0.52
Typical(dopamine, be contraindicated in shock)
Evidence: 0.39
¬ Typical(dopamine, be used in shock)
0.49
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.76
Evidence: 0.73
Salient(dopamine, be contraindicated in shock)
Evidence: 0.90
¬ Salient(dopamine, be prefered over adrenaline in cardiogenic shock)
0.48
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.76
Evidence: 0.52
Typical(dopamine, be contraindicated in shock)
Evidence: 0.55
¬ Typical(dopamine, be given for cardiovascular shock)
0.41
Rule weight: 0.85
Evidence weight: 0.64
Similarity weight: 0.76
Evidence: 0.58
Plausible(dopamine, be contraindicated in shock)
Evidence: 0.85
¬ Plausible(dopamine, be prefered over adrenaline in cardiogenic shock)
0.41
Rule weight: 0.85
Evidence weight: 0.63
Similarity weight: 0.76
Evidence: 0.58
Plausible(dopamine, be contraindicated in shock)
Evidence: 0.88
¬ Plausible(dopamine, be used in shock)
0.36
Rule weight: 0.85
Evidence weight: 0.57
Similarity weight: 0.76
Evidence: 0.52
Typical(dopamine, be contraindicated in shock)
Evidence: 0.90
¬ Typical(dopamine, be prefered over adrenaline in cardiogenic shock)

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.89
Similarity weight: 1.00
Evidence: 0.73
Salient(dopamine, be contraindicated in shock)
Evidence: 0.52
¬ Typical(dopamine, be contraindicated in shock)
Evidence: 0.79
¬ Remarkable(dopamine, be contraindicated in shock)

Typical implies Plausible

0.37
Rule weight: 0.48
Evidence weight: 0.78
Similarity weight: 1.00
Evidence: 0.58
Plausible(dopamine, be contraindicated in shock)
Evidence: 0.52
¬ Typical(dopamine, be contraindicated in shock)

Typicality and Rermarkability incompatibility between siblings

0.07
Rule weight: 0.14
Evidence weight: 0.64
Similarity weight: 0.76
Evidence: 0.79
¬ Remarkable(dopamine, be contraindicated in shock)
Evidence: 0.46
¬ Typical(vasopressin, be used in shock)